Irritable bowel syndrome is an extremely prolific medical condition that affects between 10% and 15% of the total world population. Although the condition is extremely common, many individuals that suffer from Irritable bowel syndrome, or IBS, are unaware that the symptoms they are experiencing are caused by it.
While not every individual that sufferers from Irritable bowel syndrome seeks medical treatment, the condition still accounts for over 3 million medical consultations every year, and is the most common digestive disorder diagnosed by gastroenterologists. As the symptoms of irritable bowel syndrome are particularly distressing and have a significant impact on quality of life, the condition accounts for more than $21 billion dollars in lost productivity due to work absenteeism every year.
In this article, we’ll take a look at a new probiotic solution for treating irritable bowel syndrome called Kijimea IBS. We’ll proceed to explore the benefits of Kijimea IBS and find out how it works to help you decide whether it’s the right IBS treatment for you.
What is IBS?
The most common symptom of irritable bowel syndrome is pain in the abdomen, but the gastrointestinal symptoms of IBS are the most debilitating. Irritable bowel syndrome causes abdominal cramping and bloat, as well as constant painful gas. Individuals suffering from irritable bowel syndrome often experience chronic diarrhea that alternates with painful constipation, and often observe mucus in their stool.
In severe cases, irritable bowel syndrome can even lead to rectal bleeding, continuous abdominal pain, and dangerous, unhealthy weight loss. The causes of irritable bowel syndrome are poorly understood, and are linked to a variety of factors, including the dietary content, high stress levels, hormonal imbalances, and other systemic illnesses that interfere with digestive function.
The Difficulty of Treating IBS
Treating irritable bowel syndrome can be extremely difficult. The primary treatment for IBS consists of self-therapy, with doctors often recommending individuals suffering from the condition consume a high fiber diet, practice physical exercise and mental relaxation techniques, and even incorporate cognitive behavioural therapy into their lifestyle.
The pharmaceutical treatments available to individuals suffering from irritable bowel syndrome are difficult to balance, as they consist of either diarrhea medications or constipation medications. Balancing the consumption of these medications is complex, as IBS symptoms tend to fluctuate on a day to day basis. Ongoing long-term reliance on these drugs to manage bowel movements also causes severe damage to the digestive system that can worsen the condition significantly.
One of the most promising new cutting edge treatments for irritable bowel syndrome, however, is probiotics. The digestive system is home to billions upon billions of tiny microorganisms that regulate digestive health and immune system function. New research demonstrates that the root cause of IBS may be linked to an unhealthy microbiome.
As a result, many clinical investigations have been performed into the efficacy of probiotic supplements as a treatment for irritable bowel syndrome. The most promising solution, bacteria strain B. bifidum MIMBb75, has been incorporated into a revolutionary new IBS treatment called Kijimea IBS that is providing IBS sufferers around the world with instant relief from the condition.
What is Kijimea IBS?
The Kijimea IBS solution has been developed in cooperation with a number of international research institutions. Over several years, a joint research effort isolated a specific bacterial strain, B. bifidum MIMBb75, that has been proven to eliminate the symptoms of irritable bowel syndrome and dramatically improve the quality of life of individuals that suffer from the condition.
Clinical investigations into the benefits of B. bifidum MIMBb75 have demonstrated that it can relieve digestive disorders, soothe abdominal pain, minimize bloating and abdominal distension, and lower the urgency for bowel movements experienced by IBS patients. The B. bifidum MIMBb75 strain used in Kijimea IBS is manufactured in a clinical laboratory environment in Italy and the US, adhering to extremely high quality standards.
The Kijimea IBS formula contains no ingredients that could potentially cause an allergic response, such as lactose, gluten, dairy products, tree nuts, soy, wheat, fish, or peanuts, and is thus suitable for individuals with highly specific dietary requirements. Importantly, the Kijimea IBS solution doesn’t interact with any other medications, making it one of the safest IBS treatments available on the market.
Kijimea IBS consists of two capsules daily, taken with every meal. In most clinical trials, IBS patients taking the Kijimea IBS solution experienced benefits after just one week, although the creators of the solution advise taking the supplement for at least four weeks to ensure the B. bifidum MIMBb75 strain has sufficient time to colonize the digestive tract.
The Science Behind Kijimea IBS
There are several peer-reviewed clinical trials that have proven the effectiveness of the B. bifidum MIMBb75 strain used in the Kijimea IBS formula to treat irritable bowel syndrome. A randomized clinical trial performed in Italy in 2011 found provided 122 IBS patients with a B. bifidum MIMBb75 supplement once daily for four weeks.
After the treatment period, the group taking a B. bifidum MIMBb75 supplement experienced a significant improvement over the placebo group in the severity of IBS symptoms, leading the research team that ran the trial to conclude that B. bifidum MIMBb75 is able to effectively alleviate IBS and reduce the severity of all IBS symptoms simultaneously.
This trial is supported by another clinical trial performed at the University of Toronto in 2013, in which a research team observed the effects of B. bifidum MIMBb75 on the intestinal microbiome of mice. The trial found that the B. bifidum MIMBb75 strain is exceptionally efficient in colonizing the digestive tract permanently, providing evidence that the Kijimea IBS solution is able to survive and thrive in the digestive system.
Kijimea IBS Verdict
Probiotic solutions have been a popular treatment for irritable bowel syndrome for many years, but until now there has been a lack of clinical scientific evidence that supports the use of a specific strain in treating the condition. The Kijimea IBS solution offers individuals suffering from irritable bowel syndrome one of the first clinically proven treatments for IBS that is supported by real science.
If you suffer from irritable bowel syndrome and are seeking an effective, natural, drug-free, and fast-acting solution, Kijimea IBS is one of the best options available.